| BAM type | Treatment | Outcome mean 3 months | |
|---|---|---|---|
| Type 1 (n = 17) | Started (12), dose increased (3),same dose (2) | Better 12 | No change 3Drug not tolerated 2 |
| Type 2 (n = 24) | Started (16), dose increased (2),same dose (5), declined (1) | Better 11 | No change 7Drug not tolerated 6 |
| Type 3 (n = 8) | Started (7), dose increased (1) | Better 4 | No change 2Drug not tolerated 2 |